Skip to content

Breakthrough Therapies for Skin Diseases™

Alphyn Doses First Patient in Phase 2b Clinical Trial of Zabalafin Hydrogel for Atopic Dermatitis

Alphyn
Breakthrough Therapies for Skin Diseases
Alphyn
  • About
    • What We Do
    • Leadership & Board
    • Science Advisory
  • Platform
    • Zabalafin Platform
  • Pipeline
    • Atopic Dermatitis
    • Epidermolysis Bullosa
  • News
    • Press Releases
    • In the News
    • Clinical Presentations
    • Events
  • Contact Us
  • About
    • What We Do
    • Leadership & Board
    • Science Advisory
  • Platform
    • Zabalafin Platform
  • Pipeline
    • Atopic Dermatitis
    • Epidermolysis Bullosa
  • News
    • Press Releases
    • In the News
    • Clinical Presentations
    • Events
  • Contact Us

International Society of Atopic Dermatitis Poster Presentation: Itch Reduction and Quality of Life Improvement in AD for First Human Use of Zabalafin

Alphyn Logo 1

NEWS PROVIDED BY
Alphyn Biologics
October 26, 2024, 19:30 ET

N432_Neal-KOLLER_Itch-Reduction-and-Quality-of-Life-Improvement-in-AD-for-First-Human-Use-of-Zabalfin

CONTACTS

 

Corporate:
Neal Koller
[email protected]
(410) 690-8687

 

Media:
Susan Thomas
[email protected]
(619) 540-9195

BREAKTHROUGH THERAPIES FOR SKIN DISEASESTM

Alphyn Biologics is a life science company creating a new class of drugs, Multi-Target Therapeutics® (MTT™), for more powerful and effective therapies.

Our Mission is to create breakthrough therapies for skin diseases – the most difficult, severe and prevalent.

Navigation
  • Home
  • About
    • About Alphyn
    • What We Do
    • Leadership & Board
    • Science Advisory
  • Platform
    • Platform
    • AB-101 Multi-Target Therapeutics
  • Pipeline
    • Pipeline
    • Atopic Dermatitis
    • Epidermolysis Bullosa
  • News
    • News
    • Press Releases
    • In the News
    • Clinical Presentations
    • Events
  • Contact Us

Copyright 2025, Alphyn Biologics, Inc. All rights reserved. | Website Design by ABWeb Beacon.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to Top